文献速递物质与行为成瘾

耐力运动经肝脏合成N-乙酰神经氨酸缓解甲基苯丙胺渴求行为

Endurance exercise relieves methamphetamine craving behaviors via hepatic synthesis of N-Acetylneuraminic acid.
PubMed 文献 · Mol Psychiatry · 2026-05-30

该研究在甲基苯丙胺成瘾者中开展48周有氧运动并抑制药物渴求行为,代谢组学显示运动个体血清N-乙酰神经氨酸(Neu5Ac)升高。啮齿类模型重复了行为改善及循环和纹状体Neu5Ac升高,并证明运动刺激肝脏合成Neu5Ac调节纹状体突触蛋白以减轻寻药行为。

要点

  • 48周有氧运动可抑制甲基苯丙胺成瘾者的药物渴求行为。
  • 运动个体血清Neu5Ac升高,啮齿类模型循环和纹状体Neu5Ac也升高。
  • 运动刺激肝脏合成Neu5Ac,经肝-脑轴调节纹状体突触蛋白。

核心结论

  • 耐力运动通过肝脏合成Neu5Ac调节纹状体突触蛋白,缓解甲基苯丙胺渴求行为,提出肝-脑轴机制。

研究设计与样本

  • 研究纳入甲基苯丙胺成瘾者进行48周有氧运动干预,并开展代谢组学分析。
  • 研究在甲基苯丙胺暴露的啮齿类模型中进行行为学与Neu5Ac水平验证。

主要发现

  • 48周有氧运动使甲基苯丙胺成瘾者的药物渴求行为受到抑制。
  • 代谢组学显示运动个体血清Neu5Ac特异性升高。
  • 啮齿类模型重复了行为改善及循环和纹状体Neu5Ac水平升高。
  • 运动刺激肝脏组织合成Neu5Ac,进而调节纹状体突触蛋白以减轻寻药行为。

临床怎么用

  • 耐力运动可作为促进甲基苯丙胺成瘾者戒断和功能康复的干预手段。
  • 肝脏Neu5Ac合成及纹状体突触蛋白或为运动戒断效应的潜在机制靶点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Methamphetamine (METH) addiction causes serious psychiatric and neurological disorders, while the overall efficacy of current interventions remains unsatisfactory. Endurance exercise is one effective approach to facilitate drug abstinence and functional rehabilitation, although its exact mechanism has not been fully elucidated. In the current work, we successfully suppressed drug craving behaviors in METH addicts by 48 weeks of aerobic exercise, and a metabolomics study indicated the elevation of serum N-Acetylneuraminic acid (Neu5Ac) specifically in exercised individuals. Further studies in rodent models of METH exposure replicated both behavioral improvement and the increase of Neu5Ac levels in circulation and the striatum. More importantly, we demonstrated that exercise stimulated the hepatic tissues to synthesize Neu5Ac, which modulates synaptic protein in the striatum to alleviate METH-seeking behaviors. In sum, our results propose a liver-brain axis in which exercise reshapes liver metabolism to facilitate drug abstinence.

来源:Mol Psychiatry,查看原文。版权归原作者所有。

引用

  1. Li X, Xu J, Wei C, et al. Endurance exercise relieves methamphetamine craving behaviors via hepatic synthesis of N-Acetylneuraminic acid. Mol Psychiatry. 2026. PMID: 42218336. doi:10.1038/s41380-026-03658-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。